Literature DB >> 26545762

[Stereotactic radiotherapy augments the immune response].

Esther G C Troost1,2,3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26545762     DOI： 10.1007/s00066-015-0923-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  12 in total

1.  Whole body irradiation; radiobiology or medicine?

Authors:  R H MOLE
Journal:  Br J Radiol       Date:  1953-05       Impact factor: 3.039

2.  Radiotherapy and immune checkpoint blockade: potential interactions and future directions.

Authors:  David C Binder; Yang-Xin Fu; Ralph R Weichselbaum
Journal:  Trends Mol Med       Date:  2015-06-16       Impact factor: 11.951

3.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

4.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

5.  Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.

Authors:  Michael T Milano; Alan W Katz; Hong Zhang; Paul Okunieff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-13       Impact factor: 7.038

Review 6.  Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives.

Authors:  N H Rekers; E G C Troost; C M L Zegers; W T V Germeraad; L J Dubois; P Lambin
Journal:  Cancer Radiother       Date:  2014-08-30       Impact factor: 1.018

7.  Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).

Authors:  Dirk De Ruysscher; Rinus Wanders; Angela van Baardwijk; Anne-Marie C Dingemans; Bart Reymen; Ruud Houben; Gerben Bootsma; Cordula Pitz; Linda van Eijsden; Wiel Geraedts; Brigitta G Baumert; Philippe Lambin
Journal:  J Thorac Oncol       Date:  2012-10       Impact factor: 15.609

8.  The abscopal effect associated with a systemic anti-melanoma immune response.

Authors:  Emily F Stamell; Jedd D Wolchok; Sacha Gnjatic; Nancy Y Lee; Isaac Brownell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-05       Impact factor: 7.038

9.  Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours.

Authors:  Giuseppe V Masucci; Peter Wersäll; Rolf Kiessling; Andreas Lundqvist; Rolf Lewensohn
Journal:  J Transl Med       Date:  2012-05-22       Impact factor: 5.531

10.  Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy.

Authors:  Guido Kroemer; Laurence Zitvogel
Journal:  Oncoimmunology       Date:  2012-07-01       Impact factor: 8.110
View more
  3 in total

1.  Checkpoint inhibitors and radiation treatment in Hodgkin's lymphoma : New study concepts of the German Hodgkin Study Group.

Authors:  C Baues; R Semrau; U S Gaipl; P J Bröckelmann; J Rosenbrock; A Engert; S Marnitz
Journal:  Strahlenther Onkol       Date:  2016-10-04       Impact factor: 3.621

Review 2.  Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation.

Authors:  Lisa Deloch; Anja Derer; Josefin Hartmann; Benjamin Frey; Rainer Fietkau; Udo S Gaipl
Journal:  Front Oncol       Date:  2016-06-20       Impact factor: 6.244

3.  Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.

Authors:  Heinz Schmidberger; Matthias Rapp; Anne Ebersberger; Silla Hey-Koch; Carmen Loquai; Stephan Grabbe; Arnulf Mayer
Journal:  Strahlenther Onkol       Date:  2018-10-08       Impact factor: 3.621
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.